Tag: Jessica Bowring
Firms advise on GSK’s USD2.2bn RAPT buy, accesses China drug
British pharmaceutical giant GSK has entered an agreement to acquire US-based clinical-stage biopharmaceutical company RAPT Therapeutics for around USD2.2 billion
British pharmaceutical giant GSK has entered an agreement to acquire US-based clinical-stage biopharmaceutical company RAPT Therapeutics for around USD2.2 billion
While stock exchanges lower barriers to atrract emerging sector issuers, regulators focus on accountability of listco and intermediaries at the top corporate level